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Abstract
Background: Mucocutaneous leishmaniasis (MCL), a protozoan infectious disease, is very rare in Iran despite the
endemicity of both cutaneous and visceral forms. It is transmitted by the Phlebotomus sand fly. The lip is considered
one of the extraordinary sites. Lesions usually initiate with erythematous papules, slowly enlarges and then it ulcerates.
The diagnosis of MCL encompasses epidemiological, clinical and laboratory aspects. Usually, the combination of some
of these elements is necessary for the final diagnosis. So, lip leishmaniasis lesions can be challenging to diagnose.
Case presentation: We presented seven rare cases of lip leishmaniasis. Tissue impression smear, culture, PCR and
phylogenetic analysis were carried out for explicit diagnosis. Skin scraping investigation showed several Leishmania spp.
amastigotes in the cytoplasm of macrophages. Culture examination was positive for Leishmania spp. PCR was positive
for L. major, L. tropica, and L. infantum. Differential diagnosis includes orofacial granulomatosis, basal cell carcinoma,
squamous cell carcinoma, and mesenchymal tumors. The cases were treated with systemic meglumine antimoniate
(Glucantime®). No relapses were observed during 1 year of follow-up. Early detection of the infection are necessary in
order to start effective treatment and prevent more serious complications.
Conclusions: In this paper, we reported seven rare cases of lip leishmaniasis in Iran, emphasized the importance of
clinical and diagnostic features of lesions, characterized the phylogenetic kinship of isolated parasites, and reviewed the
literature on lip leishmaniasis.
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Background
Leishmaniasis is a group of infectious disease, caused by
protozoan parasites belonging to the genus Leishmania
(order Kinetoplastida). It is transmitted by sand flies of
Phlebotomus and Lutzomyia species. Reservoirs are
represented by a wide range of mammals, and more
rarely, humans [1].
Leishmaniases present a wide spectrum of clinical
manifestations including cutaneous (CL), diffuse cutane-
ous (DCL), mucocutaneous (MCL), and visceral leish-
maniasis (VL) [1]. CL is endemic in half of the 31
provinces of Iran, and is a great health problem [2].
From the clinical vista, CL is characterized by skin le-
sions that vary in presentation from papules to plaques
to ulcers. These lesions can cause varying amounts of
scarring depending on the number and size of lesions
[3]. Although localized lymphadenopathy may be present
in the area of the cutaneous lesion, systemic complica-
tions from this form of leishmaniasis are rare [3].
MCL is characterized by the scatter of skin ulcers to
encompassing tissues, specifically inner nostril wall to
larynx and mouth [3]. Moreover, there may be cases in
which the MCL would be seen without cutaneous
lesions. In fact, in 30% of MCL cases, patients do not re-
call the presence of a primary cutaneous lesion [3].
Primary mucosal leishmaniasis is very rare in Iran in
spite of high prevalence of cutaneous and visceral forms.
The lip involvement is very rare and may imitate orofa-
cial granulomatosis such as Crohn’s disease, sarcoidosis,
foreign body giant cell granuloma and Melkersson-
Rosenthal syndrome [4]. Other differential diagnosis in-
cludes basal cell carcinoma, squamous cell carcinoma,
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mesenchymal tumors, and mycotic infections. Because
of its heterogeneous and underestimated clinical presen-
tation [5, 6], MCL is often perplexed and remains a
diagnostic challenge for the clinicians and scientists.
The diagnosis of MCL includes epidemiological, clin-
ical and laboratory aspects. Generally, the combination
of some of these constituents is necessary for the final
diagnosis [7]. Unfortunately, delayed diagnosis and the
lack of consensus on optimal treatment can frequently
lead to inappropriate management of the disease [8].
In this report, we presented seven rare cases of lip
leishmaniasis in Iran, emphasized the importance of
clinical and diagnostic features of lesions, characterized
the phylogenetic relationship of isolated parasites, and
reviewed the literature on oral leishmaniasis. Also, we
highlighted the important role of the clinicians in the
diagnosis of perioral leishmaniasis lesions, which are
unusual and can be confounded with other diseases,
especially in individuals living or traveling in certain
geographic regions where the parasite is endemic.
Case presentation
Case 1
A 65-year-old woman was referred to the Fajr Health
Center. The chief complaint was a lip lesion that began
2 months prior as a slowly enlarging nodule. Patient re-
ported that the lesion began as a small soft mass, which
ulcerated later. Clinical examination showed a necrotic
ulcer of the left lower lip vermillion. The lip was
erythematous and edematous from midline to the left
commissure mediolaterally (Fig. 1a). With suspicion of
basal cell carcinoma and squamous cell carcinoma, skin
scraping, culture, and PCR were accomplished. Touch
impression smears and culture were positive and the
parasite was characterized by PCR as L. tropica.
Case 2
A 75-year-old woman came to the Dermatology Clinic
of Saadi Hospital complaining about a lesion on his right
lower lip. She reported that the lesion appeared about
3 months before. The clinical examination revealed a
round nodular lesion in the right lower lip which was
slightly shiny and red colored. Palpation of the lesion
revealed a firm consistency (Fig. 1b). The differential
diagnosis of a nodular lesion of the lip included: neopla-
sia (basal cell carcinoma), and tumors from mesenchy-
mal origin (fibroma, lipoma, and neuroma). Giemsa
stain and culture were negative. PCR depicted the para-
site as L. tropica.
Case 3
A 40-year-old, generally healthy woman complained of
persistent lip enlargement and sore that appeared after
several days of fever and had been present for 2 months.
At clinical examination, the left side of the upper lip
appeared erythematous and distended, with overlying
yellow crusting lesion extending to the wet line. No
lymphadenopathy was associated (Fig. 1c). Giemsa-
stained smears and culture were positive (Fig. 2). PCR
identified the parasite as L. major.
Case 4
A 28-year-old man expressed displeasure about a swell-
ing localized to the left side of the upper lip. The patient
Fig. 1 a An erythematous, calloused, crusted left lower lip ulcerative plaque in patient 1. b A round shiny and red colored nodular lesion with
hard consistency in the right inferior lip of patient 2. c An erythematous, edematous, and elliptical ulcerative plaque of the left upper lip with
overlying yellow crusting lesion extending to the wet line in patient 3. d Sore swelling, with well-defined edges and scaling, involving the left side
of the upper lip in patient 4. e A deep red-colored ulcer covered with mild hemorrhagic crusts and severe swelling of the lower lip in patient 5.
f Mild swelling of the superior lip, in addition to ulceration, yellow crusting, scaling and bleeding in patient 6. g A severe swelling cheilitis, with
crusting, scaling and fissuring lesion of the right superior lip in patient 7
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also stated that the swelling had appeared about
2 months before and that it rapidly enlarged up to the
current morphology and size. Clinical examination
showed the presence of a swelling which involved the
left side of the upper lip. The surface of the swelling was
slightly erythematous and irregular, because of the pres-
ence of lesion and scaling (Fig. 1d). Consistency was
parenchymatous-hard. With suspicion of mycotic infec-
tion, laboratory tests were carried out. Slit dermal
smears and culture were positive. PCR characterized the
parasite as L. tropica.
Case 5
A 10-year-old girl was referred to the Dermatology
Clinic of Saadi Hospital. The patient had become in-
fected with CL on the left side of her mentum 3 months
before. Three weeks prior to referral, the lesion had
spread to the mucosal part of the lower lip. The patient
improved diffuse severe swelling of the lower lip. On
physical examination, erythema, ulceration, and scaling
of the left side of the mentum were detected. There was
a diffuse swelling cheilitis of the lower lip extra to ulcer-
ation and bleeding of the labial mucosa (Fig. 1e).
Giemsa-stained smears and culture were positive. PCR
identified the parasite as L. major.
Case 6
An 8-year-old girl presented to the Leishmaniasis research
laboratory of the Fajr Health Center with complaint of
wound on her upper lip. The lesion started 3 months prior
as a small nodule in the center of the upper lip which
slowly enlarged over a few weeks and then ulcerated. Clin-
ical examination showed an indurated, crusted, and scaled
necrotic ulcer with swelling on the midline of the upper
lip, extending to the vermilion. There was purulent dis-
charge from the lesion (Fig. 1 f). With suspicion of cheilitis
granulomatosa, slit dermal scraping, culture and PCR
were performed. Giemsa-stained smear and culture were
positive. PCR portrayed the parasite as L. major.
Case 7
A 4-year-old girl presented with a 2 month history of in-
creasing swelling and painful ulcer on the right upper
lip. On clinical examination, an erythematous infiltrated,
crusted, scaled and fissured plaque of the upper lip lead-
ing to macrocheilitis was observed. Cervical lymph
nodes were noticed to be enlarged (Fig. 1g). With suspi-
cion of granulomatous macrocheilitis; slit impression
smear, culture and PCR were achieved. Just PCR was
positive and characterized the parasite as L. infantum.
The studied patients were examined in the Dermatol-
ogy Clinic of Saadi Hospital and Fajr Health Center from
January 2014 to the end of December 2015. All patients
were came from endemic regions of Fars province. A
structured questionnaire was used to collect clinical and
therapeutic data from all patients.
The margin dermal scrapings were prepared with a no.
15 disposable sterile surgical blade (Unicut, Chicago,
USA) to make a slit in the border of the lesion. Dermal
tissues were stained with Giemsa (Merck, Darmstadt,
Germany), and exhibited amastigotes by light micro-
scope. Employing Giemsa, amastigotes are seen within
the cytoplasm of macrophages as pale blue oval bodies
with a dark blue nucleus and a small rod-shaped kineto-
plast with a specified mitochondrial frame that contains
extra-nuclear DNA.
In addition, an aspirate from the active indurated mar-
gins of the same lesions was transferred to two tubes of
the modified NNN culture medium. Modified NNN
medium consists of two phases, horse blood agar base
and an overlay Locke’s solution. The specimens were inoc-
ulated into the liquid phase of the biphasic medium and
incubated. Positive cultures were run in RPMI-1640
medium (Gibco, Frankfurt, Germany) supplemented with
10% heat inactivated FCS (Gibco, Frankfurt, Germany),
100 U/mL penicillin, and 100 μg/mL streptomycin (Gibco,
Frankfurt, Germany) for mass cultivation. Promastigotes
were harvested and kept at -20 °C until used.
Total genomic DNA was extracted from each clinical
sample using the AccuPrep® Genomic DNA Extraction
Kit (Bioneer, Daejeon, Korea), according to manufac-
turer’s instructions. The quantification and quality con-
trol of the DNA extraction procedures were performed
using a nano spectrophotometer (NanoDrop 1000,
Thermo Fisher Scientific, Waltham, Massachusetts,
USA). The DNA was stored at −20 °C until being used.
Fig. 2 Touch impression smear in patient 3. Numerous intracellular and
scattered extracellular amastigotes are present (Giemsa stain; original
magnification, ×1000). Kinetoplasts are visible in many amastigotes
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The conserved area of the minicircle kDNA from the
Leishmania species was amplified by Semi-Nested PCR.
The primers LINR4 (forward) (5’-GGG GTT GGT GTA
AAA TAG GG-3’), LIN17 (reverse) (5’-TTT GAA CGG
GAT TTC TG-3’), and LIN19 (reverse) (5’-CAG AAC
GCC CCT ACC CG-3’) were used for amplification [9].
Standard PCR was carried out with 40 cycles, each con-
sisting of 30 s at 94 °C, 30 s at 52 °C (for LINR4 and
LIN17) or 58 °C (for LINR4 and LIN19), 1 min at 72 °
C, and a final extension at 72 °C for 10 min in an
Eppendorf thermal cycler (Hamburg, Germany). PCR
products were visualized by UV after electrophoresis on
1.5% agarose gel using TAE buffer and staining with
GelRed (Biotium Inc., Hayward, CA). All primers were
synthesized by Macrogen Genomics Laboratories
(Macrogen, Seoul, Korea). A 650-bp fragment was amp-
lified for L. major, whereas a 760-bp and 720-bp frag-
ments were amplified for L. tropica and L. infantum,
respectively (Fig. 3).
The PCR products were purified by using QIAquick
Gel Extraction Kit (QIAGEN, Hilden, Germany) and se-
quenced through the sequencing service of Macrogen
Genomics Laboratories (Seoul, Korea). The resulting se-
quences were aligned and compared with those of exist-
ing sequences related to Leishmania in GenBank. A
Maximum Likelihood (ML) tree was constructed using
the MEGA-7 program [10], and genetic distances were
calculated with the Maximum Composite Likelihood
method. The sequences of three patients of L. tropica
showed 100% identity to the published isolate IranJW-
trop (AB678350). Also, these three isolates showed 99%
identity to the published isolates from UK, Egypt, and
Iran (AF308689, X84845, and KM491168) (Fig. 4a). The
sequences of three patients of L. major showed 100%
identity to the published isolate IranJWmaj (AB678349),
In addition, the three L. major showed 99%, 99% and
98% identity to the published isolates from UK and Iran
(AF308685, KM555292, and KM555295) respectively
(Fig. 4b). The sequence of L. infantum showed 99% iden-
tity to the published isolate IranJWinf (AB678348). Plus,
this isolate showed 98% identity to the published isolate
from Spain (EU437407) (Fig. 4c).
The patients received intramuscular injections of
Meglumine antimoniate (Glucantime®; Sanofi-Aventis,
Paris, France), 20 mg/kg/day over a 3-week period with
good results [7, 8]. All lesions resolved after 3 weeks of
therapy. After 1 year of follow up, the patients were
completely normal and no relapses were observed.
Discussion
Cutaneous leishmaniasis is a protozoan-induced disease
known to affect people in 98 tropical, subtropical, and
Mediterranean countries [1]. The incubation period of CL
ranges from 2 weeks up to several months, and a wide
spectrum of clinical presentations arranging from cutane-
ous ulceration to various degrees of mucosal involvement
Fig. 3 Electrophoresis of PCR products of DNA extracted from positive smears and cultures. The seven lanes contained the products from
positive controls of L. tropica (lane 6) and L. major (lane 7), lip lesions due to L. major (lanes 1, 4, 5), L. infantum (lane 2), L. tropica (lane 3), and a
molecular size marker (MM)
Mohammadpour et al. BMC Infectious Diseases  (2017) 17:96 Page 4 of 7
[3]. CL is the most prevalent and is characterized by the
presence of ulcers with a well-defined erythematous
border and a central crust that is often hemorrhagic and
located in exposed areas of the body [3, 7].
In recent years, there has been an intensifying in the
number of reports for rare variants of CL in Old World
[11]. MCL most usually influences the upper respiratory
tract with lesions principally in the oral and nasal mu-
cosa and occasionally in the laryngeal and pharyngeal
mucosa [12–18]. These lesions are ordinarily associated
with nasal congestion, pain, erythema, edema, halitosis,
bleeding, serous rhinorrhea, epistaxis, dysphagia, and
dysphonia [19]. The importance of the MCL is in the pos-
sibility of having presentations that may determine de-
structive, disfiguring and disabling injuries, with major
repercussions in psychosocial aspect of the individual [19].
The first commitment and sole mucosal involvement
of the lip region is very uncommon. Lip leishmaniasis is
characterized clinically by the gradual and proceeding
expansion of one or both lips and macrocheilitis is the
final presentation [20–23]. A papule, nodule or plaque
often demonstrate within the swelling undergoes an
ulceration which may be covered by crusts and scaling
[20–23]. The consistency of the entire lesion is
parenchymatous-hard [22, 23]. Lip involvement in leish-
maniasis may result from direct extension of nearby skin
lesions, as occurred in case 5, or from hematogenous or
lymphatic dissemination of Leishmania amastigotes from
the skin [19]. Patients with lip leishmaniasis are in good
general health, however, case 7 in our study was noticed
to have cervical lymphadenopathy. This is in accordance
with a previous report of localized leishmaniasis of the
larynx [24]. It has been hypothesized that L. infantum
strains involved in isolated ML, have developed different
resistance to high/low temperature, attaining the capabil-
ity to live electively in mucous membranes [6]. In case 5,
nodular crusted plaque localized on the left side of the
mentum was representative for CL and it was the clue for
us that lip lesion could also be a Leishmania lesion.
In MCL, the clinical demonstration at the perioral site
is atypical and can be deceiving. Accordingly, clinical
diagnosis of lip leishmaniasis is frequently a challenge
with a significantly delayed diagnosis or even an
Fig. 4 a, b, c Phylogenetic relationship among various Leishmania
species to each other as inferred by Maximum Likelihood tree based
on minicircle kDNA gene. Numbers on branches are percentage
bootstrap values of 1,000 replicates. All positions with less than 95%
site coverage were eliminated. The evolutionary distances between
sequences were computed using the Maximum Composite Likelihood
method and are in the units of the number of base substitutions per
site. The scale bar indicates an evolutionary distance of 0.10 nucleotides
per position in the sequence. The reference sequences accession
numbers are inserted. Evolutionary analyses were conducted
in MEGA-7
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erroneous clinical diagnosis of malignancy [12, 19, 25].
The most important diseases that must be taken into ac-
count in differential diagnosis are herpes labialis [26],
syphilitic chancre [27], Melkersson-Rosenthal syndrome
[28], orofacial granulomatosis [28], cheilitis granuloma-
tosa [29, 30], Wegener granulomatosis [12, 19, 25], oral
Crohn’s disease [31], sarcoidosis [32, 33], skin tubercu-
losis [34], discoid lupus erythematosus [34], lymphoma
[34], foreign body giant cell granuloma [12, 19, 25, 28],
leprosy [35], mycotic infection [36], fibroma, lipoma,
and neuroma [37], basal cell carcinoma [38], and squa-
mous cell carcinoma [34, 39]. The diagnosis is easier to
make if typical CL lesions are present elsewhere on the
skin. However, this was observed in only case 5.
Identification of leishmania parasites in dermal macro-
phages by skin biopsy or dermal scraping can confirm
the diagnosis. When performing the slit smear, it is im-
portant to scrape tissue from the inside of the lesion and
from the edges of the cut. However, in chronic lesions,
parasites may be scarce. Therefore, failure to visualize
amastigotes on histopathology does not exclude the
diagnosis of MCL. In this context, culture, IFA and PCR
can be amongst significant diagnostic techniques [7].
Detection of the kDNA of Leishmania spp. by semi-
nested PCR in the oral mucosal specimen and clinical
course of the disease verified the diagnosis of MCL. PCR
is now the diagnostic method of choice for molecular
confirmation of cases of MCL [40]. In this study, L.
tropica, L. major, and L. infantum were the identified
species in this case series.
Involvement of the lip can be treated with intralesional
injections, systemic treatment, or their combination de-
pending on the clinical manifestation and infective spe-
cies. Intralesional injections are associated with burning
sensation, pain, inflammation, and vasovagal reaction [41].
Systemic treatment is usually more effective than local,
although less tolerated because of increased toxicity. The
widely used therapeutics for treatment of mucosal
leishmaniasis are: pentavalent antimony compounds
(Pentostam® and Glucantime®), liposomal amphotericin
B (Ambisome®), pentamidine, oral azole compounds,
and miltefosine [7, 8, 41]. Recommended follow-up
times vary, although 12 months has been suggested for
CL and MCL [12].
Conclusion
In conclusion, we highlight a case series of lip leishman-
iasis which are rare and can be confused with other dis-
eases. In addition, the present report emphasizes the
importance of a multidisciplinary approach in the diag-
nosis and treatment of lip leishmaniasis. These unusual
clinical presentations of leishmaniasis should be consid-
ered in differential diagnosis of rebellious lip lesions by
physicians practiced both in endemic and non-endemic
regions, since MCL is ascending in these areas due to in-
creasing rate of traveling, as tourists or military
personnel, to endemic regions. Clinician should kept in
mind leishmaniasis in the differential diagnosis of
orofacial granulomatosis and other inflammatory and
neoplastic diseases.
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